Biojournals.com Latest Cancer Publications http://www.biojournals.com/Cancer.html Latest publications on Cancer en-us biojournals@sci7.com hourly 1 2000-01-01T12:00+00:00 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665974 Human myeloid dendritic cells for cancer therapy: does maturation matter? Dendritic cells form the connection between innate and adoptive mechanisms ... Vaccine. 2010 Jul 19;28(32):5153-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665940 Kidney cancer: MASS criteria predict good clinical outcome. Nat Rev Urol. 2010 Jul;7(7):366. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665937 Bladder cancer: Gene-expression signature in urine indicates aggressive disease. Nat Rev Urol. 2010 Jul;7(7):364. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665936 Prostate cancer: Local treatment enhances the efficacy of ADT. Nat Rev Urol. 2010 Jul;7(7):363. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665935 Prostate cancer: Is fracture prevention therapy cost-effective in patients with prostate cancer treated with ADT? Nat Rev Urol. 2010 Jul;7(7):363. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665934 Prostate cancer: The mire of modifiable risk factors. Nat Rev Urol. 2010 Jul;7(7):362. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665932 Kidney cancer: Role of partial nephrectomy continues to expand. Nat Rev Urol. 2010 Jul;7(7):360. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665931 Prostate cancer: Time to trial statins? Nat Rev Urol. 2010 Jul;7(7):359. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665908 Estimating lifetime or episode-of-illness costs under censoring. Many analyses of healthcare costs involve use of data with varying periods ... http://dx.doi.org/10.1002/hec.1640 Health Econ. 2010 Jul 28. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665892 Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. BACKGROUND:: Secondary lymphedema is a debilitating, chronic, progressive ... http://dx.doi.org/10.1002/cncr.25458 Cancer. 2010 Jul 27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665891 A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas. BACKGROUND:: The authors evaluated a 3-week schedule of bevacizumab in ... http://dx.doi.org/10.1002/cncr.25462 Cancer. 2010 Jul 27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665890 Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma. BACKGROUND:: Bortezomib has preclinical and clinical in B-cell lymphomas, ... http://dx.doi.org/10.1002/cncr.25509 Cancer. 2010 Jul 27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665889 Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients? BACKGROUND:: In vitro and in vivo studies suggested that combination of ... http://dx.doi.org/10.1002/cncr.25312 Cancer. 2010 Jul 27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665888 Examining the association between delay in diagnosis and decreased survival in bladder cancer. Sound Health Care System, Seattle, Washington. http://dx.doi.org/10.1002/cncr.25290 Cancer. 2010 Jul 27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20665887 The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. BACKGROUND:: BRCA1 or BRCA2 (BRCA1/2)-mutated ovarian carcinomas may ... http://dx.doi.org/10.1002/cncr.25439 Cancer. 2010 Jul 27.